- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01742962
Prevalence of Neglected Side Effects to Radical Prostatectomy
The purpose of this exploratory data collection is to strengthen our knowledge of some of the rarer distresses following surgical removal of the prostate. In general these are:
- Side effects related to sexuality, including:
- Altered perception of orgasm,
- Orgasm associated pain,
- Penile shortening and deformity.
- Side effects related to urinary incontinence.
- Urinary tract infection after operation.
- Influence of distress on sexual quality of life.
- Influence of distress on the patient´s sex drive.
In addition information on a range of demographics and information on the patient´s erectile function will be collected.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Approximately 1 out of 6 men will, at some point of their life become diagnosed with prostate cancer. Treatment options included medication therapy, radiation therapy, and surgery. This data collection aims to gather information on some of the lesser known distresses experienced by patients following surgical removal of the prostate gland.
Erectile dysfunction and urinary incontinence remain common, but thoroughly investigated side effects. Thus they will not be of primary interest here, but considered factors for correlation. During the last couple of years, a series of lesser known side effects have come to investigators attention. These include altered perception of orgasm, orgasm related pain, sexual-related urinary incontinence, and shortening -and impairing deviations of the penis. Few studies have investigated these side effects, and clear knowledge of why, and how often these problems arise, remain scarce. This study will contribute to that knowledge.
In addition, the questionnaire will include a series of exploratory questions, concerning lower urinary tract infections, treatment satisfaction, alcohol and urinary incontinence, reasons for abandoning treatment for erectile dysfunction, and an assessment of libido prior to and after radical prostatectomy.
The data collection will include approximately 400 patients from the department of urology at the University Hospital in Herlev, Copenhagen, Denmark. A questionnaire will be sent to patients together with a stamped addressed envelope in order to optimize the response rate. Results will be kept in a separate database from personal information.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Herlev, Denmark, 2730
- Copenhagen University Hospital in Herlev, Denmark
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All patient who have undergone radical prostatectomy at the department of urology, Copenhagen University Hospital, Herlev, between 3 months and 3 years before initiation of the study.
Exclusion Criteria:
- Incontinence associated with sexual activity Prior to surgery
- Peyronies disease Prior to surgery
- Orgasm related pain Prior to surgery
- Anorgasmia Prior to surgery
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Radical prostatectomy for prostate cancer
Prior treatment with open or robot assisted laparoscopic prostatectomy.
|
Prior treatment with open or robot assisted laparoscopic prostatectomy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of Urinary incontinence in relation to sexual activity measured as percentage of the population.
Time Frame: A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy.
|
The percentage of the study population experiencing urinary incontinence when engaging in sexual activity.
|
A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy.
|
|
Incidence of altered perception of orgasm measured as percentage of the population.
Time Frame: A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy.
|
The percentage of the study population experiencing altered perception of orgasm.
|
A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy.
|
|
Incidence of orgasm related pain measured as percentage of the population.
Time Frame: A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy.
|
The percentage of the study population experiencing orgasm related pain.
|
A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy.
|
|
Incidence of impairing deviations or loss of length of the penis measured as percentage of the population.
Time Frame: A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy.
|
The percentage of the study population experiencing impairing deviations or loss of length of the penis.
|
A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of lower urinary tract infections following radical prostatectomy
Time Frame: A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy.
|
We want to know how large a percentage of patients treated with radical prostatectomy are experiencing a lower urinary tract infection post surgery.
|
A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy.
|
|
Incidence of alcohol related incontinence in patients undergone radical prostatectomy
Time Frame: A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy.
|
Does alcohol exacerbate incontinence symptoms?
|
A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy.
|
|
Impact of radical prostatectomy on the patients libido.
Time Frame: A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy.
|
Does radical prostatectomy influence patients libido?
|
A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy.
|
|
Patterns of use and discontinuation of use of aids for erectile dysfunction.
Time Frame: A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy.
|
A series of questions will investigate the patients use of aids for erectile dysfunction and reasons for discontinuation.
|
A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy.
|
|
Patient satisfaction with treatment.
Time Frame: A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy.
|
Assessed by a global satisfaction scale, and an evaluation of fulfillment of expectations prior to treatment.
|
A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy.
|
|
How do the patients gather knowledge of their disease?
Time Frame: A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy.
|
From which sources do the patients get their knowledge of prostate cancer.
|
A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Anders U. K. Frey, Stud.Med., Copenhagen University Hospital in Herlev, Denmark
- Study Director: Mikkel M. Fode, Dr., Copenhagen University Hospital in Herlev, Denmark
- Study Chair: Jens Sønksen, Professor, Copenhagen University Hospital in Herlev, Denmark
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2007-58-0015 / HEH.750.19-31
- H-2-2012-FSP43 (OTHER: Denmark: The Regional Committee on Biomedical Research Ethics)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostate Cancer
-
Cancer Institute and Hospital, Chinese Academy...RecruitingProstate Cancer Castration-resistant Prostate CancerChina
-
Roswell Park Cancer InstituteRecruitingObesity | Overweight | Cancer Survivor | Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage A Prostate Cancer | Stage... and other conditionsUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingProstate Cancer Castration-resistant Prostate CancerChina
-
Jonsson Comprehensive Cancer CenterProgenics Pharmaceuticals, Inc.TerminatedRandomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer (PSMA-dRT)Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Stage I Prostate...United States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Ryan Kohlbrenner, MDRadiological Society of North AmericaCompletedProstate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Prostate Carcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage...United States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate...United States
-
Barbara Ann Karmanos Cancer InstituteGenentech, Inc.CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Roswell Park Cancer InstituteAIM ImmunoTech Inc.Active, not recruitingProstate Adenocarcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer... and other conditionsUnited States
Clinical Trials on Radical prostatectomy for prostate cancer
-
Fudan UniversityUniversity College, LondonUnknownProstate Cancer MetastaticChina
-
Roswell Park Cancer InstituteTerminated
-
National Taiwan University HospitalUnknownProstate Cancer | Immune Profile | Circulating Cancer Cells | Clinical CorelationTaiwan
-
The Krongrad InstituteUnknownProstatitis | Chronic Prostatitis With Chronic Pelvic Pain SyndromeUnited States
-
IRCCS San RaffaeleRecruiting
-
Instituto do Cancer do Estado de São PauloRecruiting
-
Lithuanian University of Health SciencesRecruitingProstate Cancer (Adenocarcinoma) | Radical Prostatectomy | Prostate Cancer (Diagnosis) | Prostate Specific Antigen | Prostate Cancer (Post Prostatectomy)Lithuania
-
Kartal City HospitalCompleted
-
University of LeipzigHeinrich-Heine University, Duesseldorf; University Hospital Heidelberg; Klinikum...Completed
-
Mayo ClinicTerminatedAdenocarcinoma | Prostatic NeoplasmsUnited States